NDRG2 Antibodies

Santa Cruz Biotechnology offers a broad range of NDRG2 monoclonal antibodies for research focused on understanding NDRG2 protein functions. NDRG2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NDRG2, or N-myc downstream-regulated gene 2, belongs to the NDRG family and plays crucial roles in cellular differentiation, proliferation, and stress response. Research has shown NDRG2's involvement in various physiological and pathological conditions, including cancer and neurodegenerative diseases. NDRG2 expression patterns vary across different tissues and cell types, making it an important focus for developmental and disease-related studies. Investigating NDRG2 can reveal valuable insights into its potential as a biomarker and therapeutic target. Current research indicates NDRG2's significance in cell signaling pathways and tumor suppression mechanisms. Understanding NDRG2's molecular interactions and regulatory mechanisms continues to be an active area of investigation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of NDRG2's role in health and disease.